ATRX and central nervous system cancer: ATRX and DAXX act as tumor suppressor proteins and are typically mutated in cells exhibiting ALT-like characteristic gliomas (Lovejoy et al., 2012; Gulve et al., 2022; Clatterbuck Soper and Meltzer, 2023).